Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes
Détails
ID Serval
serval:BIB_37926B477868
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes
Périodique
Experimental Cell Research
ISSN
0014-4827 (Print)
Statut éditorial
Publié
Date de publication
12/1987
Volume
173
Numéro
2
Pages
425-30
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Dec
Research Support, Non-U.S. Gov't --- Old month value: Dec
Résumé
The effect of RU 486, a synthetic steroid that is a powerful antagonist of glucocorticoid hormones, was tested on the transcription of several glucocorticoid-regulated genes in different cell types: inflammatory murine macrophages and two human mammary gland-derived cell lines, MDA-MB-231 and HBL-100. The transcription of genes which are positively regulated by glucocorticoids (e.g., tissue-type plasminogen activator and c-myc in mammary cells, c-fos in macrophages) and that of genes which are negatively regulated by these agents (e.g., urokinase-type plasminogen activator in all three cell types, TNF-a and IL-1 in macrophages) was explored. RU 486 almost completely prevented the effects of dexamethasone on the transcription of these various genes. When added alone, RU 486 had essentially no agonist activity.
Mots-clé
Animals
Cell Line, Transformed
Dexamethasone/*antagonists & inhibitors/pharmacology
Estrenes/*pharmacology
Humans
Interleukin-1/genetics
Macrophages/enzymology
Mice
Mifepristone
Plasminogen Activators/*genetics/metabolism
RNA, Messenger/biosynthesis
Tissue Plasminogen Activator/*genetics/metabolism
Transcription, Genetic/*drug effects
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha/genetics
Urinary Plasminogen Activator/*genetics/metabolism
Pubmed
Web of science
Création de la notice
25/01/2008 8:29
Dernière modification de la notice
20/08/2019 13:26